According to Global Blue Group's latest financial reports and stock price the company's current Operating Margin is -19.66%. At the end of 2022 the company had an Operating Margin of -68.03%.
Year | Operating Margin | Change |
---|---|---|
2022 | -68.03% | -92.96% |
2021 | -966.39% | -11266.47% |
2020 | 8.65% | -41.74% |
2019 | 14.86% | 0.58% |
2018 | 14.77% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 22.88% | -216.38% | ๐บ๐ธ USA |
Medtronic MDT | 17.17% | -187.33% | ๐ฎ๐ช Ireland |
Boston Scientific BSX | 11.27% | -157.32% | ๐บ๐ธ USA |
Edwards Lifesciences EW | 31.50% | -260.22% | ๐บ๐ธ USA |
Stryker Corporation SYK | 16.21% | -182.45% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.